Abstract. The aim of the present study was to assess the genetic risk for atherothrombotic cerebral infarction (ACI) in men and women separately as well as in individuals with or without conventional risk factors for atherosclerosis and thereby to contribute to the personalized prevention of ACI. The study population comprised 2705 unrelated Japanese individuals (1244 men, 1461 women), including 636 subjects (372 men, 264 women) with ACI. Subjects with ACI and controls either had or did not have conventional risk factors for atherosclerosis, including hypertension, hypercholesterolemia, and diabetes mellitus. The genotypes for 202 polymorphisms of 152 candidate genes were determined by a method that combines polymerase chain reaction and sequence-specific oligonucleotide probes with suspension array technology. Multivariable logistic regression analysis and a stepwise forward selection procedure revealed that 11 different polymorphisms were significantly (P<0.005) associated with ACI in women or men or in individuals with or without hypertension, hypercholesterolemia, or diabetes mellitus: the 584C➝T polymorphism of LIPG, 5665G➝T of EDN1, and G➝A of CCL11 in women; 677C➝T of MTHFR, 1323C➝T of ITGB2, 3932T➝C of APOE, and -231A➝G of EDNRA in men; -572 G➝C of IL6 in hypertensive individuals; -403G➝A of CCL5 and G➝A of COMT in individuals with hypercholesterolemia; and 3932T➝C of APOE and A➝G of TNFSF4 in diabetic individuals. Polymorphisms associated with ACI may thus differ between women and men as well as among individuals with different risk factors. Stratification of subjects on the basis of sex or conventional risk factors for atherosclerosis may therefore be important in order to achieve the personalized prevention of ACI with the use of genetic information.
Introduction
Stroke is the third most common cause of death after cancer and heart disease and is the leading cause of acquired disability in adults (1) . In the United States, approximately 700,000 individuals suffer a new or recurrent stroke and nearly 160,000 die from stroke-related causes each year. The total number of individuals who have experienced a stroke is 5.5 million (2) . In Japan, the prevalence of stroke is 1.4 million, with nearly 132,000 deaths from this condition occurring each year (Ministry of Health, Labor, and Welfare of Japan).
Ischemic stroke, which accounts for approximately 80% of all strokes, is a complex disorder. The main cause of ischemic stroke is atherothrombosis, with the principal and treatable risk factors including hypertension, hypercholesterolemia, and diabetes mellitus (3) . In addition to these conventional risk factors, genetic variants are important in the pathogenesis of ischemic stroke (4, 5) . Recent genetic epidemiological studies have thus identified several genes related to the prevalence of stroke, including those for interleukin-6 (6,7), methylenetetrahydrofolate reductase (8, 9) , paraoxonase (10), phosphodiesterase 4D (11), 5-lipoxygenase activating protein (12) , and cyclooxygenase 2 (13) . However, the genetic determinants of ischemic stroke remain largely unknown.
We hypothesized that gene polymorphisms related to atherothrombotic cerebral infarction (ACI) might differ between women and men as well as among individuals with or without conventional risk factors for atherosclerosis. We have therefore performed an association study of 202 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 18: 871-883, 2006 871 Genetic risk for atherothrombotic cerebral infarction in individuals stratified by sex or conventional risk factors for atherosclerosis polymorphisms and ACI for women and men separately as well as for individuals with or without hypertension, hypercholesterolemia, or diabetes mellitus. Our aim was to assess the genetic risk for ACI in men and women as well as in individuals with or without conventional risk factors for atherosclerosis and thereby to contribute to the personalized prevention of ACI.
Materials and methods
Study population. The study population comprised 2705 unrelated Japanese individuals (1244 men, 1461 women) who either visited outpatient clinics of or were admitted to one of the participating hospitals (Gifu Prefectural Gifu, Tajimi, and Gero Hot Spring Hospitals; Hirosaki University Hospital; Reimeikyo Rehabilitation Hospital; and Yokohama General Hospital) between October 2002 and March 2005. A total of 636 consecutive subjects (372 men, 264 women) with ACI was enrolled in the study. The diagnosis of ischemic stroke was based on the occurrence of a new and abrupt focal neurological deficit, with neurological symptoms and signs persisting for more than 24 h; it was confirmed by positive findings in computed tomography or magnetic resonance imaging (or both) of the head. The type of stroke was determined according to the Classification of Cerebrovascular Diseases III (14) . Individuals with cardiogenic embolic infarction, lacunar infarction, transient ischemic attack, hemorrhagic stroke, cerebrovascular malformations, brain tumors, or traumatic cerebrovascular diseases were excluded from the study, as were those with atrial fibrillation in the absence or presence of valvular heart disease.
The 2069 control subjects (872 men, 1197 women) visited outpatient clinics of the participating hospitals for an annual health checkup. They had no history of ischemic or hemorrhagic stroke or other cerebral diseases; of coronary heart disease, peripheral arterial occlusive disease, or other atherosclerotic diseases; or of other thrombotic, embolic, or hemorrhagic disorders.
Subjects with ACI and controls either had or did not have conventional risk factors for atherosclerosis, including hypertension (systolic blood pressure of ≥140 mmHg or diastolic blood pressure of ≥90 mmHg, or both), hypercholesterolemia (serum total cholesterol of ≥5.72 mmol/l), diabetes mellitus (fasting blood glucose of ≥6.93 mmol/l or hemoglobin A 1c of ≥6.5%, or both), obesity [body mass index (BMI) of ≥25 kg/ m 2 ], and cigarette smoking (≥10 cigarettes daily). The study protocol complied with the Declaration of Helsinki and was approved by the Committees on the Ethics of Human Research of Mie University School of Medicine, Hirosaki University School of Medicine, Gifu International Institute of Biotechnology, and participating hospitals. Written informed consent was obtained from each participant.
Selection of polymorphisms.
With the use of public databases, we selected 152 candidate genes that might be associated with ACI on the basis of a comprehensive overview of vascular biology; platelet function; leukocyte, lymphocyte, and monocyte-macrophage biology; coagulation and fibrinolysis cascades; neurological factors; as well as lipid, glucose, and homocysteine metabolism and other metabolic factors. We further selected 202 polymorphisms of these genes, most located in the promoter region, exons, or splice donor or acceptor sites of introns, that might be expected to result in changes in the function or expression of the encoded protein (15) .
Genotyping of polymorphisms.
Venous blood (7 ml) was collected into tubes containing 50 mmol/l EDTA (disodium salt), and genomic DNA was isolated with a kit (Genomix; Talent, Trieste, Italy). Genotypes of the 202 polymorphisms were determined (G&G Science, Fukushima, Japan) by a method that combines the polymerase chain reaction and sequence-specific oligonucleotide probes with the use of suspension array technology (Luminex 100; Luminex, Austin, TX). Detailed methodology for genotyping was described previously (16) .
Statistical analysis. Clinical data were compared between subjects with ACI and controls by the unpaired Student's t-test. Qualitative data were compared by the Chi-square test. Allele frequencies were estimated by the gene counting method, and the Chi-square test was used to identify departure from Hardy- Table I . Characteristics of male and female subjects with ACI and controls. 
Data for age and BMI are means ± SD.
-
Weinberg equilibrium. In the initial screen, the genotype distribution of each autosomal polymorphism was compared by the Chi-square test (3x2) between subjects with ACI and controls. For gene polymorphisms located on the X chromosome, allele frequencies were compared by the Chi-square test (2x2). Polymorphisms related (P<0.05) to ACI were further examined by multivariable logistic regression analysis with adjustment for covariates (with the exception of that used for stratification of subjects), with ACI as a dependent variable and independent variables including age, sex (0: woman; 1: man), BMI, smoking status (0: nonsmoker; 1: smoker), metabolic variables (0: no history of hypertension, diabetes mellitus, or hypercholesterolemia; 1: positive history), and genotype of each polymorphism. Each genotype was assessed according to dominant, recessive, and additive (additive 1 and 2) genetic models, and the P value, odds ratio, and 95% confidence interval were calculated. Additive genetic models comprised two groups: heterozygotes versus wild-type homozygotes for the additive 1 model, and variant homozygotes versus wild-type homozygotes for the additive 2 model. We also performed a stepwise forward selection procedure to examine the effects of genotypes as well as of other covariates on ACI. Given the multiple comparisons of genotypes with ACI, we adopted the criterion of P<0.005 for significant association. For other clinical background data, a P value of <0.05 was considered statistically significant. Statistical significance was examined by two-sided tests, and statistical analyses were performed with JMP software version 5.1 (SAS Institute, Cary, NC).
Results

Association of polymorphisms with ACI in women or men.
Characteristics of female and male subjects are shown in Table I . Among women, age and the prevalence of hypertension, hypercholesterolemia, and diabetes mellitus were greater in subjects with ACI than in controls. Among men, age and the prevalence of hypertension, hypercholesterolemia, and diabetes mellitus were greater, whereas the prevalence of smoking was lower, in subjects with ACI than in controls.
The Chi-square test revealed that nine and 16 polymorphisms were related (P<0.05) to ACI in women and men, respectively (Supplementary Table I ). These polymorphisms were further analyzed for their possible association with ACI. Multivariable logistic regression analysis with adjustment for age, BMI, and the prevalence of smoking, hypertension, hypercholesterolemia, and diabetes mellitus revealed that the 584C➝T polymorphism of LIPG (dominant and additive 1 models), the G➝A polymorphism of CCL11 (dominant and additive 1 models), the 5665G➝T polymorphism of EDN1 (dominant and additive 1 models), the -572G➝C polymorphism of IL6 (recessive model), and the A➝G polymorphism of KCNJ11 (additive 2 model) were significantly (P<0.005) associated with ACI for woman (Table II) . For men, the 677C➝T polymorphism of MTHFR (recessive and additive 2 models), the 1323C➝T polymorphism of ITGB2 (dominant model), the T➝G polymorphism of THBS2 (additive 1 model), the 3932T➝C polymorphism of APOE (dominant and additive 1 models), and the -231A➝G polymorphism of EDNRA (recessive model) were significantly associated with ACI (Table III) . We also performed a stepwise forward selection procedure to examine the effects of genotypes for the genes related to ACI as well as of age, BMI, smoking, hypertension, hypercholesterolemia, and diabetes mellitus on the prevalence of ACI (Table IV) 
OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, BMI, and the prevalence of smoking, hypertension, hypercholesterolemia, and diabetes mellitus. P values of <0.005 are shown in bold.
Association of polymorphisms with ACI in the absence or presence of hypertension. Characteristics of individuals with
or without hypertension are shown in Table V . Among normotensive individuals, age and the prevalence of diabetes mellitus Table III . Multivariable logistic regression analysis of polymorphisms related to ACI in men. 
- Table IV . Effects of genotypes and other characteristics on ACI for women or men as determined by a stepwise forward selection procedure. Table V . Characteristics of subjects with ACI and controls according to the absence or presence of hypertension. 
- Table VI . Multivariable logistic regression analysis of polymorphisms related to ACI in hypertensive individuals. 
OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, BMI, and the prevalence of smoking, hypercholesterolemia, and diabetes mellitus. P values of <0.005 are shown in bold.
- Table VII . Effects of genotypes and other characteristics on ACI in the absence or presence of hypertension as determined by a stepwise forward selection procedure. 
were greater, whereas the prevalence of hypercholesterolemia was lower, in subjects with ACI than in controls. Among hypertensive individuals, age and the prevalence of diabetes mellitus were greater in subjects with ACI than in controls.
The Chi-square test revealed that five and 10 polymorphisms were related to ACI in normotensive or hypertensive individuals, respectively (Supplementary Table II) . Multivariable logistic regression analysis with adjustment for age, sex, BMI, and the prevalence of smoking, hypercholesterolemia, and diabetes mellitus revealed that no polymorphism was associated with ACI among normotensive individuals (Supplementary  Table III) . Among hypertensive individuals, the -572G➝C polymorphism of IL6 (recessive model) was significantly associated with ACI (Table VI) . A stepwise forward selection procedure revealed that, in descending order of statistical significance, age, sex, and smoking status significantly affected the prevalence of ACI in normotensive individuals (Table VII) . For hypertensive individuals, diabetes mellitus and IL6 genotype (recessive model) significantly affected the prevalence of ACI (Table VII) .
Association of polymorphisms with ACI in the absence or presence of hypercholesterolemia. Characteristics of subjects with or without hypercholesterolemia are shown in Table VIII . Among individuals with or without hypercholesterolemia, age and the prevalence of hypertension and diabetes mellitus were greater in subjects with ACI than in controls. The Chisquare test revealed that 12 and 14 polymorphisms were related to ACI in the absence or presence of hypercholesterolemia, respectively (Supplementary Table IV) . Multivariable Table VIII . Characteristics of subjects with ACI and controls according to the absence or presence of hypercholesterolemia. 
- Table IX . Multivariable logistic regression analysis of polymorphisms related to ACI in individuals with hypercholesterolemia. 
OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, BMI, and the prevalence of smoking, hypertension, and diabetes mellitus. P values of <0.005 are shown in bold.
logistic regression analysis with adjustment for age, sex, BMI, and the prevalence of smoking, hypertension, and diabetes mellitus revealed that no polymorphism was associated with ACI among individuals without hypercholesterolemia (Supplementary Table V) . Among individuals with hypercholesterolemia, the -403G➝A polymorphism of CCL5 (recessive and additive 2 models) and the G➝A polymorphism of COMT (dominant and additive 1 models) were significantly associated with ACI (Table IX) Table X) .
Association of polymorphisms with ACI in the absence or presence of diabetes mellitus.
Characteristics of subjects with or without diabetes mellitus are shown in Table XI . Age and the prevalence of hypertension were greater in subjects with ACI than in controls for both nondiabetic and diabetic individuals. The Chi-square test revealed that eight and 14 polymorphisms were related to ACI in nondiabetic and diabetic individuals, respectively (Supplementary Table VI) . Multivariable logistic regression analysis with adjustment for age, sex, BMI, and the prevalence of smoking, hypertension, and hypercholesterolemia revealed that no polymorphism was associated with ACI in nondiabetic individuals (Supplementary Table VII) . In diabetic individuals, the 3932T➝C polymorphism of APOE (dominant and additive 1 models), the 2445G➝A polymorphism of FABP2 (dominant model), and the A➝G polymorphism of TNFSF4 (additive 2 model) were significantly associated with ACI (Table XII) . A stepwise forward selection procedure revealed Table X . Effects of genotypes and other characteristics on ACI in the absence or presence of hypercholesterolemia as determined by a stepwise forward selection procedure.
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, contribution rate. Table XI . Characteristics of subjects with ACI and controls according to the absence or presence of diabetes mellitus.
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that hypertension, age, sex, and IL6 genotype (recessive model) significantly affected ACI in nondiabetic individuals (Table XIII) . Hypertension, APOE genotype (dominant model), age, TNFSF4 genotype (recessive model), GCK genotype (recessive model), and sex significantly influenced ACI in diabetic individuals (Table XIII) . The polymorphisms significantly (P<0.005) associated with ACI by both multivariable logistic regression analysis and the stepwise forward selection procedure in women or men, or in individuals with or without hypertension, diabetes mellitus, or hypercholesterolemia, are summarized in Table XIV .
Discussion
We have examined the relation of 202 polymorphisms to ACI in women or men separately as well as in individuals with or Table XII . Multivariable logistic regression analysis of polymorphisms related to ACI in diabetic individuals.
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OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, BMI, and the prevalence of smoking, hypertension, and hypercholesterolemia. P values of <0.005 are shown in bold.
- Table XIII . Effects of genotypes and other characteristics on ACI in the absence or presence of diabetes mellitus as determined by a stepwise forward selection procedure.
----------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------Diabetes mellitus (-) Diabetes mellitus (+) ----------------------------------------------------------------------------------------------------
without hypertension, hypercholesterolemia, or diabetes mellitus. Our observations suggest that polymorphisms associated with ACI may differ between men and women as well as among individuals with or without different conventional risk factors for atherosclerosis. ACI is the most common type of stroke and, in most patients, is caused by atherosclerosis (5). Atherosclerosis results from excessive inflammatory and fibroproliferative responses to various forms of insult to the endothelium and smooth muscle of the artery wall, with the participation of large numbers of growth factors, cytokines, and vasoregulatory molecules (17) . We therefore selected 152 candidate genes for ACI on the basis of a comprehensive overview of vascular, platelet, leukocyte, lymphocyte, and monocyte-macrophage biology; coagulation and fibrinolysis cascades; neurological factors; as well as lipid, glucose, and homocysteine metabolism and other metabolic factors. Indeed, the genes found to be associated with ACI may have roles in diverse aspects of the etiology of this condition, including cell adhesion (ITGB2, TNFSF4); vascular inflammation (CCL11, IL6) ; leukocyte, lymphocyte, and monocyte-macrophage biology (CCL5); vascular constriction (EDN1, EDNRA); and metabolism of lipids (LIPG, APOE), homocysteine (MTHFR), and catecholamine transmitters (COMT). Three of the 11 polymorphisms associated with ACI in the present study (677C➝T of MTHFR, 3932T➝C of APOE, and -572G➝C of IL6) have previously been associated with ischemic stroke (8, 9, 15, 18, 19) . The remaining eight polymorphisms (584C➝T of LIPG, 5665G➝T of EDN1, G➝A of CCL11, 1323C➝T of ITGB2, -231A➝G of EDNRA, -403G➝A of CCL5, G➝A of COMT, and A➝G of TNFSF4) have not been previously associated with this condition.
Association of polymorphisms with ACI in women versus
men. The 584C➝T polymorphism of LIPG, the 5665G➝T polymorphism of EDN1, and the G➝A polymorphism of CCL11 were associated with ACI in women, whereas the 677C➝T polymorphism of MTHFR, the 1323C➝T polymorphism of ITGB2, the 3932T➝C polymorphism of APOE, and the -231A➝G polymorphism of EDNRA were associated with this condition in men. The mechanisms responsible for the difference in the polymorphisms associated with ACI between men and women remain unclear. Given that, in general, the total risk for atherosclerotic disease, such as coronary heart disease and ACI, in women lags behind that in men by approximately 10 years, the mechanisms underlying the risk for ACI in women may differ from those in men at each age. The sex difference in the association of poly- Table XIV . Summary of polymorphisms significantly (P<0.005) associated with ACI as determined by multivariable logistic regression analysis and a stepwise forward selection procedure. 
HDL, high density lipoprotein; LDL, low density lipoprotein.
morphisms with ACI might be attributable to the difference in sex hormones such as estrogen between men and women, given that estrogen exerts various favorable effects on vessel wall and vasomotor function, including stimulation of the production of nitric oxide and prostaglandin I 2 as well as inhibition of the release of endothelin-1 by vascular endothelial cells (20) . Furthermore, considering that the polymorphisms examined in our study probably represent only a small proportion of those potentially associated with ACI, it remains possible that further investigations will uncover polymorphisms that are associated with ACI in both men and women.
Association of polymorphisms with ACI in the absence or presence of conventional risk factors for atherosclerosis.
Given that interactions between gene polymorphisms and conventional risk factors may be important in the etiology of ACI, we examined the effects of polymorphisms on the prevalence of ACI in the absence or presence of hypertension, hypercholesterolemia, or diabetes mellitus. The -572G➝C polymorphism of IL6 was associated with ACI in hypertensive individuals, whereas no polymorphism was associated with ACI in normotensive individuals. The -403G➝A polymorphism of CCL5 and the G➝A polymorphism of COMT were associated with ACI in subjects with hypercholesterolemia, whereas no polymorphism was associated with ACI in subjects without hypercholesterolemia. The 3932T➝C polymorphism of APOE and the A➝G polymorphism of TNFSF4 were associated with ACI in diabetic individuals, whereas no polymorphism was associated with this condition in nondiabetic subjects. These observations suggest that polymorphisms associated with ACI may differ among subjects with different conventional risk factors, although the mechanisms responsible for these differences remain to be elucidated. Given that the effects of single polymorphisms on the development of ACI are likely to be small, the association between a polymorphism and the prevalence of ACI might be influenced by the absence or presence of conventional risk factors for atherosclerosis. Furthermore, considering that hypertension, hypercholesterolemia, and diabetes mellitus probably have genetic components, there might be interactions between genes related to ACI and those related to conventional risk factors. There were several limitations to the present study. The number of subjects with ACI was relatively small after stratification of these individuals by sex or conventional risk factors. Considering the multiple comparisons of genotypes with ACI, we adopted the criterion of P<0.005 for significant association. However, this approach does not completely exclude the possibility of false positive associations. It is also possible that one or more of the polymorphisms associated with ACI in our study are in linkage disequilibrium with polymorphisms of other nearby genes that are actually responsible for the development of this condition. Furthermore, the functional relevance of the identified polymorphisms to gene transcription or to protein structure or function was not determined in the present study.
Our present observations suggest that polymorphisms associated with ACI may differ between women and men as well as among individuals with different conventional risk factors for atherosclerosis. Stratification of subjects on the basis of sex or conventional risk factors may thus be important in order to achieve the personalized prevention of ACI with the use of genetic information.
Supplementary Table I . Polymorphisms related to ACI in women or men as determined by the Chi-square test. Table II . Polymorphisms related to ACI in the absence or presence of hypertension as determined by the Chisquare test. Table III . Multivariable logistic regression analysis of polymorphisms related to ACI in normotensive individuals. 
OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, BMI, and the prevalence of smoking, hypercholesterolemia, and diabetes mellitus.
- Table IV . Polymorphisms related to ACI in the absence or presence of hypercholesterolemia as determined by the Chi-square test. 
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OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, BMI, and the prevalence of smoking, hypertension, and diabetes mellitus.
- Supplementary Table VI . Polymorphisms related to ACI in the absence or presence of diabetes mellitus as determined by the Chi-square test.
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Supplementary Table VII . Multivariable logistic regression analysis of polymorphisms related to ACI in nondiabetic individuals.
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OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, BMI, and the prevalence of smoking, hypertension, and hypercholesterolemia.
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